{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:10:23Z","timestamp":1792030223957,"version":"4.4.0"},"reference-count":30,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003887","name":"International Myeloma Foundation\u2019","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100003887","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100003887","name":"International Myeloma Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003887","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.1080\/13696998.2022.2133823","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T06:35:32Z","timestamp":1668753332000},"page":"1167-1175","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Beyond medicines\u2019 barriers: exploring the true cost of multiple myeloma"],"prefix":"10.1080","volume":"25","author":[{"given":"Mimi","family":"Choon-Quinones","sequence":"first","affiliation":[{"name":"International Myeloma Foundation, Studio City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Zelei","sequence":"additional","affiliation":[{"name":"Syreon Research Institute, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Barnett","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Keown","sequence":"additional","affiliation":[{"name":"Syreon Research Institute, Budapest, Hungary"},{"name":"Department of Medicine, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Durie","sequence":"additional","affiliation":[{"name":"International Myeloma Foundation, Studio City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Kal\u00f3","sequence":"additional","affiliation":[{"name":"Syreon Research Institute, Budapest, Hungary"},{"name":"Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00edmea","family":"Alm\u00e1si","sequence":"additional","affiliation":[{"name":"Syreon Research Institute, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Harousseau","sequence":"additional","affiliation":[{"name":"Institut de Canc\u00e9rologie de l\u2019Ouest, Saint Herblain, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[{"name":"Department of Hematology, Vrije Universiteit Brussel (VUB), Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"e_1_3_6_2_1","unstructured":"International Myeloma Foundation. Who Gets Multiple Myeloma. 2019. [cited 2021 April 7]. https:\/\/www.myeloma.org\/what-is-multiple-myeloma."},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.2128"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199202010-00001"},{"key":"e_1_3_6_5_1","unstructured":"World Health Organization (WHO) Universal health coverage 2030 (UHC); 2022. https:\/\/www.uhc2030.org\/"},{"key":"e_1_3_6_6_1","unstructured":"United Nations (UN) Agenda 2030 Agenda for Sustainable Development. 2015. https:\/\/www.un.org\/humansecurity\/agenda-2030\/"},{"key":"e_1_3_6_7_1","unstructured":"European Medicines Agency (EMA). EMA Regulatory Science to 2025. EMA\/110706\/2020. 2020. https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/ema-regulatory-science-2025-strategic-reflection_en.pdf"},{"key":"e_1_3_6_8_1","unstructured":"EUnetHTA (European network for Health Technology Assessment). 2021. https:\/\/eunethta.eu\/"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/acg2.96"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.COT.0000653340.42631.19"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.2165\/11588380-000000000-00000"},{"key":"e_1_3_6_12_1","unstructured":"Critical Appraisal Skills Programme 2018. CASP Economic Evaluation Checklist. [online]. https:\/\/casp-uk.net\/wp-content\/uploads\/2018\/03\/CASP-Economic-Evaluation-Checklist-2018_fillable_form.pdf."},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.2217\/ijh-2018-0004"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2017.1421546"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16484"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13298"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.875.875"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.12.006"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3363-3"},{"key":"e_1_3_6_21_1","first-page":"4497","volume-title":"Blood","author":"Martino M","year":"2011","unstructured":"Martino M, Pellicano G, Moscato T, et\u00a0al. At-home management of aplastic phase following high-dose melphalan and autologous haematopoietic stem cell transplantation for multiple myeloma patients: a pilot study. Blood. 2011;118(21):4497."},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.09.619"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv563"},{"issue":"1","key":"e_1_3_6_24_1","first-page":"4614","article-title":"Infectious complications in the outpatient and inpatient autologous stem cell transplantation setting for patients with multiple myeloma","volume":"132","author":"Nikonova A","year":"2018","unstructured":"Nikonova A, Zeglinski C, Husain S, et\u00a0al. Infectious complications in the outpatient and inpatient autologous stem cell transplantation setting for patients with multiple myeloma. Princess Margaret Cancer Center Experience. Blood. 2018;132(Suppl 1):4614\u20134614.","journal-title":"Princess Margaret Cancer Center Experience. Blood"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.05.018"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2019.100243"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.7342"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12876"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-110140"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13044"},{"key":"e_1_3_6_31_1","first-page":"412","volume-title":"Blood","author":"Cowan AJ","year":"2019","unstructured":"Cowan AJ, Baldomero H, Atsuta Y, et\u00a0al. The global state of hematopoietic stem cell transplantation for multiple myeloma: an analysis of the worldwide network of blood and marrow transplantation (WBMT) database and the global burden of disease study. Blood. 2019;134(Supplement_1):412."}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2022.2133823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T11:04:22Z","timestamp":1729163062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2022.2133823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1080\/13696998.2022.2133823"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2022.2133823","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}